Bio-IT World January 12, 2026
By Allison Proffitt

NVIDIA is making a massive push into healthcare and life sciences, announcing a landmark five-year, $1 billion strategic partnership with pharmaceutical giant Eli Lilly alongside major expansions of its biological AI platform today at the J.P. Morgan Healthcare Conference.

Foundational to this push into life sciences is an expansion of BioNeMo, NVIDIA’s large language model for biology announced in the fall of 2022. Kimberly Powell, NVIDIA’s VP of Healthcare and Life Sciences, described the update as a “major expansion … to a full open development platform that enables lab-in-a-loop scientific workflows for biology and drug discovery.”

Facetime Facility

The $1 billion Lilly partnership will bring this significant digital update into...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

Continue Reading

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma / Biotech, Technology
Related Articles:
Infographic: ECRI’s Top 10 Tech Hazards of 2026
Doctors Increasingly See AI Scribes in a Positive Light. But Hiccups Persist.
The Download: OpenAI’s plans for science, and chatbot age verification
AI Personas Of Synthetic Clients Spurs Systematic Uplift Of Mental Health Therapeutic Skills
Models that improve on their own are AI's next big thing

Share Article